Everything on Biotech Investing

Kylara Therapeutics' IPO represents the largest biotech raise ever, despite having no current revenue, due to promising late-stage weight-loss drug trials.

Impact: High probability of M&A activity as major pharmaceutical companies seek to acquire proven weight-loss pipelines.

— from AI Chip IPOs, Biotech Surges, and US Industrial Resurgence · OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News· Apr 20, 2026